These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 18946610

  • 41. Efficacy and safety of immunosuppressive treatment in IgA nephropathy: a meta-analysis of randomized controlled trials.
    Zhang Z, Yang Y, Jiang SM, Li WG.
    BMC Nephrol; 2019 Aug 27; 20(1):333. PubMed ID: 31455248
    [Abstract] [Full Text] [Related]

  • 42. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
    Zhu B, Chen N, Lin Y, Ren H, Zhang W, Wang W, Pan X, Yu H.
    Nephrol Dial Transplant; 2007 Jul 27; 22(7):1933-42. PubMed ID: 17405792
    [Abstract] [Full Text] [Related]

  • 43. Influence of mycophenolate mofetil on preservation of kidney function in liver transplant patients.
    Barrera-Pulido L, Espinosa-Aguilar MD, Marín D, Nuñez-Garcia F, Jiménez-Pérez M, de la Mata-Garcia M, Gómez-Bravo MA.
    Transplant Proc; 2010 Mar 27; 42(2):651-5. PubMed ID: 20304215
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Mycophenolate mofetil for induction treatment of lupus nephritis: a systematic review and metaanalysis.
    Touma Z, Gladman DD, Urowitz MB, Beyene J, Uleryk EM, Shah PS.
    J Rheumatol; 2011 Jan 27; 38(1):69-78. PubMed ID: 20952473
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
    Pham PT, Pham PC.
    Nephrol Dial Transplant; 2012 Jul 27; 27(7):2965-71. PubMed ID: 22207327
    [Abstract] [Full Text] [Related]

  • 48. Meta-analysis of mycophenolate mofetil in IgA nephropathy.
    Navaneethan SD, Viswanathan G, Strippoli GF.
    Nephrology (Carlton); 2008 Feb 27; 13(1):90. PubMed ID: 18199113
    [No Abstract] [Full Text] [Related]

  • 49. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr 15; 61(7):1029-37. PubMed ID: 8623181
    [Abstract] [Full Text] [Related]

  • 50. Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil.
    Chandrakantan A, Ratanapanichkich P, Said M, Barker CV, Julian BA.
    Nephrol Dial Transplant; 2005 Jun 15; 20(6):1214-21. PubMed ID: 15797890
    [Abstract] [Full Text] [Related]

  • 51. Mycophenolic acid therapy after cyclophosphamide pulses in progressive IgA nephropathy.
    Rasche FM, Keller F, von Müller L, Sailer LK, Karges W, Czock D.
    J Nephrol; 2006 Jun 15; 19(4):465-72. PubMed ID: 17048204
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Mycophenolate mofetil is effective in reducing lupus glomerulonephritis proteinuria.
    Borba EF, Guedes LK, Christmann RB, Figueiredo CP, Gonçalves CR, Bonfá E.
    Rheumatol Int; 2006 Oct 15; 26(12):1078-83. PubMed ID: 16736162
    [Abstract] [Full Text] [Related]

  • 54. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
    Li X, Tian J, Wu J, He Q, Li H, Han F, Li Q, Chen Y, Ni Q, Chen J.
    Clin Ther; 2009 Apr 15; 31(4):741-50. PubMed ID: 19446147
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. European Mycophenolate Mofetil Cooperative Study Group.
    Transplantation; 1999 Aug 15; 68(3):391-6. PubMed ID: 10459543
    [Abstract] [Full Text] [Related]

  • 57. Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide.
    Wang J, Hu W, Xie H, Zhang H, Chen H, Zeng C, Liu Z, Li L.
    Lupus; 2007 Aug 15; 16(9):707-12. PubMed ID: 17728363
    [Abstract] [Full Text] [Related]

  • 58. Mycophenolate mofetil plus prednisone for inducing remission of Henoch-Schönlein purpura nephritis: a retrospective study.
    Han F, Chen LL, Ren PP, Le JY, Choong PJ, Wang HJ, Xu Y, Chen JH.
    J Zhejiang Univ Sci B; 2015 Sep 15; 16(9):772-9. PubMed ID: 26365119
    [Abstract] [Full Text] [Related]

  • 59. Long-term effects of methylprednisolone pulses and mycophenolate mofetil in IgA nephropathy patients at risk of progression.
    Roccatello D, Rossi D, Marletto F, Naretto C, Sciascia S, Baldovino S, Piras D, Giachino O.
    J Nephrol; 2012 Sep 15; 25(2):198-203. PubMed ID: 21725921
    [Abstract] [Full Text] [Related]

  • 60. Severe pneumonia in mycophenolate mofetil combined with low-dose corticosteroids-treated patients with immunoglobulin A nephropathy.
    Wan QJ, Hu HF, He YC, Luan SD, Chen HT, Liu HP, Li T, Xu Y, Xu HL, Liao Y.
    Kaohsiung J Med Sci; 2015 Jan 15; 31(1):42-6. PubMed ID: 25600919
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.